UPDATE: Medicines Co. (MDCO) Says Milano Study Interim Data Inconclusive - Bloomberg

August 30, 2016 4:26 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
(Updated - August 30, 2016 4:30 PM EDT)

Medicines Co. (NASDAQ: MDCO) said interim analysis of the first 40 patients completing treatment in its Milano-Pilot study didn't meet the pre-defined efficacy threshold to stop early, according to Bloomberg. The company had hoped the analysis would allow early termination of the study, but so far data is "inconclusive."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, FDA, Management Comments

Add Your Comment